title: Progressive multifocal leucoencephalopathy with Behçet's disease: an insight into pathophysiology.
authors.affiliation: Department of Neurology.
authors.forename: Smriti
authors.initials: S
authors.lastname: Agarwal
authors.affiliation: Department of Medicine, Addenbrooke's Hospital, Cambridge, UK.
authors.forename: Jean
authors.initials: J
authors.lastname: Patrick
authors.affiliation: Department of Neurology.
authors.forename: Joanne
authors.initials: J
authors.lastname: Jones
authors.affiliation: Department of Medicine, Addenbrooke's Hospital, Cambridge, UK.
authors.forename: Rona
authors.initials: R
authors.lastname: Smith
authors.affiliation: Department of Neurology.
authors.forename: Alasdair
authors.initials: A
authors.lastname: Coles
authors.affiliation: Department of Medicine, Addenbrooke's Hospital, Cambridge, UK.
authors.forename: David
authors.initials: D
authors.lastname: Jayne
mesh_terms: D000328:Adult; D000074323:Alemtuzumab / Q000009:adverse effects; D001528:Behcet Syndrome / Q000188:drug therapy*; D001921:Brain / Q000000981:diagnostic imaging; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects*; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced*; D008279:Magnetic Resonance Imaging; D000069283:Rituximab / Q000009:adverse effects
chemical_list: D007155:Immunologic Factors; D000074323:Alemtuzumab; D000069283:Rituximab